Cape Bio Pharms
PrivateLast Round
Grant
Dec 18, 2020
Total Funding Raised
$44.78M
Company Overview
Cape Bio Pharms is a biotechnology company that produces recombinant proteins, antibodies, and enzymes using a proprietary plant-based expression platform for use in biomedical research and diagnostic applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cape Bio Pharms Comparables
Compare Cape Bio Pharms with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SwiftPharma | 84% | |
| Baiya Phytopharm | 79% | |
| KBio Inc. | 78% |
Cape Bio Pharms Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 18, 2020 | ||||
| VC Round | Aug 14, 2020 | ||||
| VC Round | May 6, 2019 | ||||
| Grant | Nov 22, 2018 | ||||
| Seed | Feb 27, 2017 |
Cape Bio Pharms Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Technology Innovation Agency | Seed |
| Stocks & Strauss Fund Manager | VC Round |
| Foundation for Innovative New Diagnostics | Grant |
| European Investment Bank Group | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2020
$45M grant received from European Investment Bank Group and FIND.
- Aug 14, 2020
Funded by Stocks & Strauss Fund Manager.
Cape Bio Pharms Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cape Bio Pharms's valuation, stock price, and market status.
Is Cape Bio Pharms a public or private company?
Cape Bio Pharms is a private company.
What is the current stock price of Cape Bio Pharms?
Cape Bio Pharms is a private company with no public stock price. Caplight tracks Cape Bio Pharms's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Cape Bio Pharms worth (valuation)?
Valuation information for Cape Bio Pharms is not publicly available.
Can I buy Cape Bio Pharms stock?
Cape Bio Pharms shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cape Bio Pharms's last funding round?
Cape Bio Pharms's most recent funding round was Grant on December 18, 2020.
Who are the main investors in Cape Bio Pharms?
Key investors in Cape Bio Pharms include Technology Innovation Agency, Stocks & Strauss Fund Manager, Foundation for Innovative New Diagnostics, European Investment Bank Group.
Will Cape Bio Pharms IPO soon?
No public IPO plans have been announced for Cape Bio Pharms.
How can I track Cape Bio Pharms secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cape Bio Pharms's secondary market activity and sign up for updates.